Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001588667 | SCV001824339 | likely benign | not provided | 2020-10-22 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001588667 | SCV002464105 | likely benign | not provided | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002276837 | SCV002565292 | likely benign | Ehlers-Danlos syndrome | 2022-06-13 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002414286 | SCV002723305 | benign | Cardiovascular phenotype | 2021-03-25 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |